Local drug firms increase market share

With foreign drug makers taking a bigger share of the domestic prescription market and mid-tier companies facing restructuring, Korea's pharmaceutical industry is expecting major changes.

According to Shinhan Investment Corporation, the domestic ethical market for outpatients in February accounted for 717.3 billion won, down a 16.1-percent decrease over the same period of last year and refl...